Wikisage, the free encyclopedia of the second generation, is digital heritage
Rivaroxaban: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 |colspan=2| <center> : rivaroxaban [https://www.whocc.no/atc_ddd_index/...") |
mNo edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
[[File:Cc-FXa-rivaroxaban.png|miniature]] | |||
==[[ATC]]== | |||
antithrombo | |||
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 | {| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 | ||
|colspan=2| <center> | |colspan=2| <center> | ||
| Line 5: | Line 9: | ||
<ref>https://karmel.miraheze.org/w/index.php?title=Rivaroxaban&oldid=11562</ref> | <ref>https://karmel.miraheze.org/w/index.php?title=Rivaroxaban&oldid=11562</ref> | ||
==Links== | |||
[https://www.ncbi.nlm.nih.gov/pubmed/31699660 Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial] | |||
{{wikidata|Q420262}} | |||
==references== | |||
{{reflist}} | {{reflist}} | ||
